MoneyWorks4Me

Cipla seeks favourable policies for domestic pharmaceutical industry

29 Jul 2019 Evaluate

Cipla has urged the government to increase fund allocation for the healthcare sector, improve ease of doing business and formulate policies that aid the domestic pharmaceutical industry.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Peers
Company Name CMP
Sun Pharma. Inds. 1844.95
Dr. Reddys Labs. 1231.45
Cipla 1389.10
Lupin 2087.80
Zydus Lifesciences 1210.95
View more..